Otsuka Holdings

4578.TPharmaceutical
Financials · Consolidated

From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.

Reports · 2
PeriodFormFiledFigures
2025-01-01 → 2025-12-31Annual2026-03-26207 figures · EDINET
2025-01-01 → 2025-06-30Half-year2025-07-3181 figures · EDINET

22 more reports are still being processed.

Segments · FY ended 2025-12
SegmentExternal salesProfit
Consumer Products¥34.6bn¥25.1bn
Nutraceuticals¥577.6bn¥57.7bn
Other¥112.4bn¥8.0bn
Pharmaceuticals¥1.74T¥445.3bn
Adjustments & eliminations—−¥56.8bn
Total¥2.47T¥536.2bn

Segment names from EDINET member IDs; not mapped to a common taxonomy.